JIN MEDICAL INTERNATIONAL LTD. - Ordinary Shares (ZJYL)
0.2097
-0.0061 (-2.83%)
NASDAQ · Last Trade: Dec 31st, 10:57 AM EST
Detailed Quote
Previous Close
0.2158
Open
0.2088
Bid
0.2095
Ask
0.2100
Day's Range
0.2088 - 0.2100
52 Week Range
0.1810 - 1.190
Volume
17,879
Market Cap
32.80M
PE Ratio (TTM)
20.97
EPS (TTM)
0.0
Dividend & Yield
N/A (N/A)
1 Month Average Volume
141,918
Chart
About JIN MEDICAL INTERNATIONAL LTD. - Ordinary Shares (ZJYL)
Jin Medical International Ltd. is a company focused on the healthcare sector, specifically engaged in the development and manufacture of innovative medical devices and equipment. The company aims to enhance patient care and medical outcomes through its advanced technologies, which cater to various medical needs. Jin Medical International is committed to research and development, striving to deliver high-quality products that meet industry standards and improve healthcare services. Through its efforts, the company seeks to contribute to the evolving landscape of healthcare and provide solutions that address both clinical and operational challenges faced by healthcare providers. Read More
The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Beijing, China, July 15, 2025 (GLOBE NEWSWIRE) -- Jin Medical International Ltd. (Nasdaq: ZJYL) (“Jin Medical”, and together with all its subsidiaries, the “Company”), a Nasdaq-listed provider of rehabilitation medical equipment, announced today that its wholly owned subsidiary, ZhongJin Medical Equipment (Anhui) Co., Ltd. (“Zhongjin Anhui”), has officially launched production at Plant No. 3 of Zhongjin Anhui’s intelligent manufacturing facility in Chuzhou, Anhui, China. With 19 years of expertise in rehabilitation technology, the Company is committed to accelerate the integration of the global rehabilitation device supply chain through its robust production and precision manufacturing capabilities.
Changzhou City, China, May 06, 2025 (GLOBE NEWSWIRE) -- Jin Medical International Ltd. (NASDAQ: ZJYL) (the “Company”) today announced that on May 2, 2025, it received a deficiency letter (the “Notice”) from the Nasdaq Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”). The Notice informed the Company that, based upon the closing bid price of the Company’s ordinary shares (“Ordinary Shares”) over the 30 consecutive business day period between March 20, 2025 and May 1, 2025, the Company is not in compliance with the requirement to maintain a minimum bid price of $1.00 per share of its Ordinary Shares for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”).
Chuzhou City, China, Oct. 10, 2024 (GLOBE NEWSWIRE) -- JIN MEDICAL INTERNATIONAL LTD. (the "Company" or “JinMed”) (NASDAQ: ZJYL), an industrial leader in Assistive Technologies (“AT”), and a manufacturer and developer of wheelchairs and living aids products, today announced the initiation of construction of JinMed’s new manufacturing facility at Chuzhou City, Anhui Province, China. JinMed (Anhui) Co., Ltd., a newly established subsidiary of JinMed, will be designated to operate the Chuzhou JinMed plant (the “New Facility”) which is established as an internationally standardized, innovative, and high-end wheelchair and electric wheelchair manufacturing factory. With higher-level production lines in place, more innovative high-quality products are expected to strengthen JinMed’s leadership in the AT industry.
